Palmitoyl Oligopeptide is a synthetic messenger peptide designed to stimulate the synthesis of structural proteins in the skin’s extracellular matrix. By mimicking natural fragments of broken-down Collagen, it signals fibroblasts to produce new tissue, effectively improving skin firmness and reducing wrinkle depth.
- INCI Name:
- Palmitoyl Oligopeptide
- Chemical/Scientific Name:
- N-Palmitoyl-Gly-His-Lys (often referring to Pal-GHK)
- Common Aliases:
- Pal-GHK, Biopeptide CL, Part of Matrixyl 3000
| Category: | Active Substances |
| Source Origin: | Synthetic |
| Comedogenic Rating: | 0 |
| Primary Industries: | Cosmetics, Dermatology |
| Solubility: | Oil and Glycol soluble |
At a Glance: Properties & Effects
| Anti-Aging/Renewal | |
| Texture Enhancement | |
| Barrier Repair | |
| Irritation Risk |
- Primary Benefits: Stimulates Collagen synthesis, increases Sodium Hyaluronate production, improves skin elasticity, and smooths fine lines.
- Potential Risks: Extremely low risk; well-tolerated by sensitive skin types.
Biological Action & Cosmetic Profile
Dermal remodeling relies heavily on specific signal molecules known as matrikines. This ingredient functions as a matrikine by tricking the skin into believing its structural proteins have been damaged. When the skin detects these peptide fragments, it initiates a repair response, activating fibroblasts to synthesize a fresh supply of Collagen and elastin. This biological feedback loop helps to maintain the density and integrity of the dermis, which naturally thins as we age.The molecular structure of this peptide includes a short chain of amino acids—typically Glycine-Histidine-Lysine (GHK)—linked to Palmitic Acid. This acylation is critical because it transforms a water-soluble peptide into a lipophilic molecule, allowing it to bypass the hydrophobic stratum corneum. Improved penetration ensures the peptide reaches the target receptors on skin cells where it can exert its regenerative effects.Clinical data suggests that Palmitoyl Oligopeptide specifically targets the production of glycosaminoglycans, such as Sodium Hyaluronate. By increasing these moisture-binding molecules within the deeper layers of the skin, the ingredient provides an internal “plumping” effect that is more substantive than the temporary hydration provided by topical humectants like Glycerin.
Broader Applications & Origins
Synthetic engineering of peptides has allowed formulators to move away from animal-derived Collagen fragments. This shift ensures high purity and high bioavailability while maintaining a vegan-friendly profile. In modern formulations, Palmitoyl Oligopeptide is frequently paired with other peptides, such as Palmitoyl Tripeptide 1 or Palmitoyl Pentapeptide 4, to create synergistic effects that target multiple pathways of skin aging.
Routine Integration
- Synergies: Works exceptionally well with Retinol and Niacinamide for comprehensive age management. It also pairs effectively with antioxidants like Ascorbic Acid to protect newly formed Collagen from oxidative stress.
- Conflicts: No documented physiological conflicts; it is compatible with most active ingredients, including direct acids and vitamins.
Clinical Consensus & Safety
The Cosmetic Ingredient Review (CIR) Expert Panel evaluated palmitoyl oligopeptides and determined they are safe for use in cosmetics at concentrations currently found in the industry. Dermatological testing across numerous studies indicates a high safety profile with negligible potential for irritation or sensitization. PubMed-indexed research confirms its efficacy in reducing wrinkle depth and improving skin texture when used consistently over a 4-to-12-week period.
Is Palmitoyl Oligopeptide the same as Palmitoyl Tripeptide-1?
Yes, in many contexts. Palmitoyl Oligopeptide is an older INCI name that was used before nomenclature became more specific. It most commonly refers to the tripeptide sequence GHK, which is now officially listed as Palmitoyl Tripeptide 1 in modern ingredient lists.
How long does it take to see results?
Clinical results for peptides generally manifest after 4 to 8 weeks of twice-daily application. This timeframe aligns with the natural turnover of the skin and the time required for fibroblasts to produce significant amounts of new structural proteins.